Streetbeat News

Stock Prices

FXY

QQQ

Major central banks are cutting interest rates to combat slowing inflation, but the Bank of Japan is diverging by raising rates, impacting global markets. This divergence is affecting the carry trade, leading to a stronger yen and impacting U.S. tech stocks, particularly the Nasdaq 100.

Portfolio Pulse from Piero Cingari

September 12, 2024 | 8:20 pm

ONMD

OneMedNet has received a notice from the Nasdaq Listing Qualifications Department due to a delay in filing its Forms 10-Q. This could impact its Nasdaq listing status.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:18 pm

WFC

Wells Fargo has entered into a formal agreement with the U.S. Office of the Comptroller of the Currency (OCC) to enhance its anti-money laundering and financial crimes risk management practices. The OCC identified deficiencies in Wells Fargo's internal controls, leading to a 4.02% drop in the company's stock price.

Portfolio Pulse from Erica Kollmann

September 12, 2024 | 8:17 pm

KDP

Keurig Dr Pepper has announced an increase in its dividend from $0.86 to $0.92 per share, reflecting the company's strong financial performance and commitment to returning value to shareholders.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:17 pm

CCI

Unusual options activity has been observed for Crown Castle (NYSE:CCI), with a significant amount of bearish sentiment among big-money traders. The options trades include 1 put and 8 calls, with a total trade value of $487,998. The price target for CCI is between $60 and $125. The stock is currently trading at $119.07, down by 0.89%, and may be overbought according to RSI indicators.

Portfolio Pulse from Benzinga Insights

September 12, 2024 | 8:17 pm

SNAP

Snap's options trading shows a bullish sentiment with 8 unusual trades, including 6 calls and 2 puts. The price range targeted by traders is $7.0 to $15.0. Snap's stock is currently trading at $9.35, up by 3.89%, but an analyst has downgraded it to Neutral with a price target of $8.0.

Portfolio Pulse from Benzinga Insights

September 12, 2024 | 8:17 pm

AUPH

Aurinia Pharmaceuticals shares rose following the announcement of a board restructuring to consist of seven members.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:17 pm

LKCO

Luokung Technology Corp. plans to implement an 8-to-1 share combination, which is a reverse stock split. This move is likely aimed at increasing the stock price to meet listing requirements or improve market perception.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:16 pm

ORCL

Oracle shares are experiencing an uptick following the company's announcement of a projected revenue of at least $104 billion for its fiscal year 2029.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:14 pm

NBIX

Neurocrine Biosciences announced that their Phase 2 study for Luvadaxistat did not meet its primary endpoint for treating cognitive impairment in schizophrenia. The company will now focus on Phase 3 development of other drugs for schizophrenia and major depressive disorder.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:11 pm